|Storage||Cool and Dry Place|
|Grade Standard||Medicine Grade|
|Usage||Clinical, hospital etc.|
Nexavar 200 mg Tablets are clinically approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma). Nexavar 200 mg Tablets (generic name : Sorafenib) has both US FDA & European Commision approval to be used in the treatment of advanced renal cancer & liver cancer. Nexavar 200 mg Tablets are available in 200 mg dosage & 60 tablets or bottle packing.